Market Insights Consumer OTC Pharmaceuticals

Other OTC Pharmaceuticals - Europe

Europe

Revenue in the Other OTC Pharmaceuticals amounts to €14.22bn in 2024. The market is expected to grow annually by 1.14% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€6,556m in 2024).
In relation to total population figures, per person revenues of €16.85 are generated in 2024.

Key regions: Canada, Worldwide, United States, Thailand, Philippines

Mercado

Región

Comparación de regiones

Moneda

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.